Non-small cell lung cancer part: I Biology, diagnosis, and staging (Q36404552)

14 August 2017

1 reference

title

Non-small cell lung cancer. Part I: Biology, diagnosis, and staging (English)

1 reference

14 August 2017

Non-small cell lung cancer part: I Biology, diagnosis, and staging (English)

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

21 October 2022

author name string

D. C. Ihde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649734

21 October 2022

J. D. Minna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1649734

21 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1649734

21 October 2022

publication date

1 March 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:0147027291900142?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

https://api.elsevier.com/content/article/PII:0147027291900142?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Current Problems in Cancer

21 October 2022

published in

1 reference

14 August 2017

volume

15

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

61-104

1 reference

Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Airways obstruction and the risk for lung cancer

21 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Familial aggregation of lung cancer among hospital patients

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Personal and family history of respiratory disease and lung cancer risk

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Genetics and smoking-associated cancers. A study of 485 families.

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Correlation of DNA adduct levels in human lung with cigarette smoking

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

International control of smoking and the US experience

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Low-tar cigarettes: bane or benefit

21 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Does breathing other people's tobacco smoke cause lung cancer?

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Involuntary smoking and lung cancer: a case-control study

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Passive smoking and lung cancer in Swedish women

21 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Asbestos exposure--quantitative assessment of risk

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Contribution of Environmental Fibers to Respiratory Cancer

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short-term work exposure

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

A case-referent study of lung cancer, occupational exposures and smoking. III. Etiologic fraction of occupational exposures

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Distribution of airborne radon-222 concentrations in U.S. homes.

21 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Risk assessment for indoor exposure to radon daughters

21 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Interaction between tobacco smoking and occupational exposures in the causation of lung cancer

21 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Dietary vitamin A and lung cancer: results of a case-control study among chemical workers

21 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diet and lung cancer. A review of the epidemiologic evidence in humans

21 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Rationale and design of cancer chemoprevention studies in Seattle

21 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer

21 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.

21 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations

21 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene

21 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient

21 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

21 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer

21 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer

21 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

21 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Human small-cell lung cancers show amplification and expression of the N-myc gene

21 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

21 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Expression of the c-myb oncogene in human small cell lung carcinoma

21 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer

21 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course

21 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene

21 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing

21 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs

21 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The human L-myc gene is expressed as two forms of protein in small cell lung carcinoma cell lines: detection by monoclonal antibodies specific to two myc homology box sequences

21 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs

21 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma.

21 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities

21 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

21 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Karyotypic characterization of established cell lines and short-term cultures of human lung cancers

21 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

A 3p deletion in small cell lung carcinoma

21 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p

21 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall-cell lung cancer

21 October 2022

69

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

21 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Gene losses in human tumours

21 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung

21 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

21 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer

21 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers

21 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Loss of genes on the short arm of chromosome 11 in human lung carcinomas

21 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

21 October 2022

79

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Human retinoblastoma susceptibility gene: cloning, identification, and sequence

21 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

21 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

21 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung

21 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

p53: a frequent target for genetic abnormalities in lung cancer.

21 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

21 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines

21 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cigarette smoking and lung cancer: reanalysis of the British doctors' data

21 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Evidence for mendelian inheritance in the pathogenesis of lung cancer

21 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

21 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype

21 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer following treatment for lymphoma

21 October 2022

92

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer

21 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer

21 October 2022

95

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Multiple primary neoplasia of the head and neck and lung. The changing histopathology

21 October 2022

96

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Acute leukemia following intensive therapy for small-cell carcinoma of the lung

21 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer

21 October 2022

100

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer

21 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The changing histopathology of lung cancer.A review of 1682 cases

21 October 2022

105

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer: perspectives and prospects

21 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The role of curative radiotherapy in the treatment of lung cancer

21 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Adenocarcinoma of the lung: a tumor with a changing pleomorphic character

21 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Superior vena caval obstruction with lung cancer

21 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Superior vena cava syndrome. Clinical management

21 October 2022

113

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cardiac metastases in lung cancer

21 October 2022

114

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Terminal bronchiolar of "alveolar cell" cancer of the lung. Two hundred sixty-five cases

21 October 2022

116

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchiolar carcinoma.Report of 11 cases and review of the literature

21 October 2022

117

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchiolo-alveolar carcinoma: a correlative clinical and cytologic study

21 October 2022

118

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Multiple primary cancers of the lung, esophagus, and other sites.

21 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The significance of a solitary lung shadow in patients with colon carcinoma

21 October 2022

122

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

South London Lung Cancer Study

21 October 2022

123

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Earlier diagnosis and survival in lung cancer

21 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Early diagnosis of lung cancer

21 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Preliminary report of the lung cancer detection program in New York

21 October 2022

127

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report

21 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Sputum cytologic diagnosis of upper respiratory tract cancer

21 October 2022

132

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Results of the Mayo Lung Project: An Interim Report

21 October 2022

133

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

ProACTH: Use for early detection of lung cancer

21 October 2022

134

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer

21 October 2022

135

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with carcinoma of the lung

21 October 2022

136

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection

21 October 2022

137

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchoscopic Localization of Radiographically Occult Lung Cancer

21 October 2022

138

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Early Lung Cancer Detection and Localization

21 October 2022

139

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Radiologically occult lung cancer. Report of 26 cases

21 October 2022

141

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer

21 October 2022

143

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchoscopic Localization of Radiographically Occult Lung Cancer

21 October 2022

144

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Positive sputum cytology and negative chest roentgenograms. A surgeon's dilemma.

21 October 2022

146

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Early Lung Cancer Detection and Localization

21 October 2022

147

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diagnostic accuracy in lung cancer; comparison of techniques used in association with flexible fiberoptic bronchoscopy

21 October 2022

148

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Brusings, washings, or biopsy? Obtaining maximum value from flexible fiberoptic bronchoscopy in the diagnosis of cancer

21 October 2022

149

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diagnostic accuracy in peripheral lung lesions. Factors predicting success with flexible fiberoptic bronchoscopy

21 October 2022

150

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diagnostic value of fiberoptic bronchoscopy in lung cancer presenting as mediastinal mass(ES)

21 October 2022

151

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung: early detection of patients at high risk of relapse

21 October 2022

152

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Transbronchial needle aspiration of a bronchial carcinoid tumor

21 October 2022

153

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Comparison of transbronchial fine needle aspiration biopsy, aspiration of bronchial secretion, bronchial washing, brush biopsy and forceps biopsy in the diagnosis of lung cancer

21 October 2022

154

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchial needle aspiration in the diagnosis of bronchial carcinoma

21 October 2022

155

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Assessment of Endoscopically Visible Bronchial Carcinomas

21 October 2022

158

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients

21 October 2022

160

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Bronchogenic Carcinoma Presenting as an Endobronchial Mass

21 October 2022

161

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Postal survey of bronchoscopic practice by physicians in the United Kingdom

21 October 2022

163

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Deaths and Complications Associated with Fiberoptic Bronchoscopy

21 October 2022

164

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The physiologic consequences of saline lobar lavage in healthy human adults

21 October 2022

165

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Flexible fiberoptic bronchoscopy and fluoroscopically guided transbronchial biopsy in the management of solitary pulmonary nodules

21 October 2022

168

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma

21 October 2022

169

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Flexible bronchoscopy in nonvisualized carcinoma of the lung

21 October 2022

170

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Use of the bronchofiberscope for bronchial brush biopsy. Diagnostic results and comparison with other brushing techniques.

21 October 2022

171

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cytology in fiberoptic bronchoscopy. Comparison of bronchial brushing, washing and post-bronchoscopy sputum

21 October 2022

172

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Transbronchial lung biopsy via the fiberoptic bronchoscope. Experience with 107 consecutive cases and comparison with bronchial brushing

21 October 2022

173

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Flexible fiberoptic bronchoscopy

21 October 2022

174

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Transbronchial needle aspiration of peripheral pulmonary nodules

21 October 2022

176

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Transbronchial needle aspiration staging of bronchogenic carcinoma

21 October 2022

177

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Thin needle aspiration biopsy of thoracic lesions: impact on hospital charges and patterns of patient care

21 October 2022

178

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Pulmonary neoplasms diagnosed with transthoracic needle biopsy

21 October 2022

180

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Percutaneous transthoracic aspiration needle biopsy

21 October 2022

181

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Small-cell carcinoma of the lung. Cytological, roentgenologic, and clinical findings in a consecutive series diagnosed by fine-needle aspiration biopsy

21 October 2022

182

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Cytologic diagnosis of lung cancer. Principles and problems

21 October 2022

183

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The clinical outcome of needle aspirations of the lung when cancer is not diagnosed

21 October 2022

184

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Pathology of non-small cell lung cancer. New diagnostic approaches

21 October 2022

186

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma

21 October 2022

191

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin

21 October 2022

193

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas

21 October 2022

194

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

21 October 2022

195

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

A system for the clinical staging of lung cancer

21 October 2022

198

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

A new international staging system for lung cancer

21 October 2022

199

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

21 October 2022

201

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer.

21 October 2022

202

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Evaluation of intrathoracic extent of lung cancer by plain chest radiography, computed tomography, and magnetic resonance imaging

21 October 2022

204

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer

21 October 2022

205

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Value of CT in the preoperative assessment of lung cancer: a survey of thoracic surgeons.

21 October 2022

207

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Non-small cell lung cancer

21 October 2022

209

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer: a surgeon's approach

21 October 2022

210

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging

21 October 2022

211

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Radionuclide scans in staging of carcinoma of the lung

21 October 2022

212

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer

21 October 2022

213

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria

21 October 2022

215

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Patterns of failure in patients with inoperable carcinoma of the lung

21 October 2022

216

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

21 October 2022

217

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

21 October 2022

218

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung

21 October 2022

219

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

21 October 2022

220

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population

21 October 2022

221

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

Tumor Cell Lines Established in Vitro: An Independent Prognostic Factor for Survival in Non-Small-Cell Lung Cancer

21 October 2022

224

1 reference

https://api.crossref.org/works/10.1016/0147-0272(91)90014-2

21 October 2022

Identifiers

1 reference

14 August 2017

1 reference